Previous 10 | Next 10 |
Data lock has been announced, and top line data is to be expected within a few weeks. Trial duration hints towards longer survival than Standard of Care. No other drug can explain this long survival. Cel-Sci might have a potential blockbuster drug in the making. For furt...
Data is Locked. NWBO's Data Lock announcement boosted their Market Cap to nearly $2B. Full Data announcement is imminent. CEL-SCI appears to be preparing a BLA. Positive data will bring a share price between $80 - $200. For further details see: CEL-SCI: Data Lock...
Should These Be On Your List Of Penny Stocks To Buy Today? Penny stocks have become synonymous with both institutional and retail investors in the past six months. There are a few reasons why penny stocks are seeing so much popularity in that time frame. For one, penny stocks are de...
Why Are These Penny Stocks Seeing Newfound Attention? Penny stocks have continued to bring in newfound attention in the stock market. The term penny stock itself simply means any stock that is trading under $5. As you can see, this opens up quite a long list of possibilities. And wi...
Are These Biotech Penny Stocks On Your Watch List Right Now? While the traders digest the latest news in the stock market today, penny stocks remain a focal point. These cheap stocks are some of the most exciting especially during times where volatility might be lacking in the broad...
When it comes to winning biotech stocks this year, coronavirus vaccine developers automatically come to many investors' minds. However, one of the top-performing stocks in the sector is Northwest Biotherapeutics (OTC: NWBO) , which focuses on immunotherapies that treat can...
Palm Beach, FL – October 21, 2020 – Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical companies. Adverse effects, such as recurrence of cancer and organ failure, associated with conventional chemotherapies and rising demand for technolo...
With Data Lock just announced, Top Line Date is imminent. Numerous statistical and mathematical markers from available data shine a positive light on potential trial results. The company may have a lucrative option even if median Overall Survival does not meet the second...
Northwest Biotherapeutics ([[NWBO]] +2.6%) announced that the database for the Phase III trial of DCVax-L for Gliobastoma has been locked.Pipeline:Independent service firms managing the clinical trial will now arrange for the independent statisticians to have access to the unblinded raw ...
Northwest Biotherapeutics Announces Data Lock of Phase III Trial PR Newswire BETHESDA, Md., Oct. 5, 2020 BETHESDA, Md. , Oct. 5, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® perso...
News, Short Squeeze, Breakout and More Instantly...
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property PR Newswire Complementary to Technology & IP Already Owned or In-Licensed; Significant Step in Building a Leading Dendritic Cell Franchise ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors PR Newswire BETHESDA, Md. , March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® ...